pharmaceuticals

One lawsuit was filed by eight Northwest Florida counties and four cities, and another by Miami-Dade and two South Florida cities. They allege that McKinsey & Company “played an integral role in creating and deepening the opioid crisis.”

Patients with insurance coverage say the cost set by drugmaker Amylyx Pharmaceutical is fueling insurance delays or denials, and sometimes exorbitant out-of-pocket expenses.

While supporters cheer the PASTEUR Act as an essential strategy to stem the rise of antibiotic-resistant pathogens, critics call it a multibillion-dollar giveaway to Big Pharma.

Colorado, New Hampshire and New Mexico are also seeking federal permission to import cost-lowering prescription drugs from Canada. President Joe Biden endorsed the approach in his 2020 campaign but has yet to approve any state plan.

The grand jury petition is focused in part on statements by pharmaceutical companies about the efficacy of the vaccines.

Some people say it’s reasonable for densely populated areas to receive more settlement funds, since they serve more of those affected. But others worry this overlooks rural communities disproportionately harmed by opioid addiction.

The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.

Increasingly, the FDA is asking drugmakers to remove unproven uses from older drugs that haven't delivered on early results. And drugmakers seeking accelerated approvals are facing tougher hurdles.

Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.

Makers of products like Children's Tylenol say they're trying to keep up with big demand as RSV, flu and COVID spread. But medical experts note that kids' fevers don't always call for medicine.